openPR Logo
Press release

New Product Launches are driving the Immunoassay Market

01-15-2025 04:13 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Immunoassay Market

Immunoassay Market

The global immunoassay market is anticipated to grow at a CAGR of 6.08% during the forecast period (2024-2031). The market growth is driven by the growing number of diseases. The market is segmented by product (analyzer and consumable), technology (radioimmunoassay, counting immunoassay, enzyme immunoassays, fluoroimmunoassay, and chemiluminescence immunoassay), and geography (North America, Europe, Asia-Pacific, and the Rest of the World).

Get Free Sample link @ https://www.omrglobal.com/request-sample/immunoassay-market

Market Dynamics

· In December 2024, Roche received CE mark approval for its cobas® Mass Spec solution, which includes the cobas® i 601 analyzers and an Ionify® reagent pack of four assays for steroid hormones.

· In August 2024, Wondfo presented new products at the 76th Annual American Congress of Clinical Chemistry and Exposition of Clinical Laboratory Medicine (ADLM). The products included the new fully automatic chemiluminescence immunoassay analyzer FC-2100, the fluorescence immunoassay analyzer Finecare™ FIA Meter X1 and X2, and the automatic blood gas analyzer Ucare-6000. The immunoassay analyzer covers 0.64 sqm, and the test speed is up to 200T/h. The first result shows within 12 minutes.

· In March 2024, Sysmex Corp. launched six testing parameters, including, HISCL LH Assay Kit, HISCL FSH Assay Kit, HISCL Prolactin Assay Kit, HISCL Estradiol Assay Kit, HISCL Progesterone Assay Kit, and HISCL Testosterone Assay Kit. The parameters will be applied to gynecological and gonadal hormone immunoassay panels in Japan. The testing parameters are applicable for Automated Immunoassay System HISCL-5000/HISCL-800 (HISCL-Series) and will address a wide range of laboratory needs.

· In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd entered into a Contract Development and Manufacturing Organization (CDMO) partnership for a Cartridge-based CLIA system reagents manufacturing project. The project is aimed at manufacturing immunology equipment Mispa i60 and Mispa i121. The analyzers and reagents are sold under Agappe's brand.

· In July 2023, the Atellica CI Analyzer by Siemens Healthineers received FDA clearance. The product is available for immunoassay and clinical chemistry testing in major markets, globally.

· In September 2022, Spear Bio presented its immunoassay technology at the American Association of Clinical Chemistry's scientific meeting and clinical lab expo, in Chicago. The company unveiled the NAB-Sure™ SARS-CoV-2 neutralizing antibody (NAb) test kit. The product is useful against COVID-19 and serves various applications including COVID-19 serosurveillance, vaccine efficacy testing, and longitudinal antibody durability testing.

· In October 2022, Roche launched SARS-CoV-2 rapid antigen tests ("2.0") for COVID-19 test, for professional use (SARS-CoV-2 Rapid Antigen Test 2.0 (nasopharyngeal sampling), SARS-CoV-2 Rapid Antigen Test 2.0 Nasal (nasal sampling)) and self-testing (SARS-CoV-2 Antigen Self-Test Nasal (nasal sampling)).

Inquiry Before Buying of Immunoassay Market Report @ https://www.omrglobal.com/inquiry-before-buying/immunoassay-market

SARS-CoV-2 Rapid Antigen Test 2.01 (nasopharyngeal sampling) is a rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 in human nasopharyngeal swab samples.

SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2 (nasal sampling) is a rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal swab samples.

SARS-CoV-2 Antigen Self-Test Nasal3 is for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in human nasal samples.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Information or Query, Visit @ https://www.omrglobal.com/industry-reports/immunoassay-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Product Launches are driving the Immunoassay Market here

News-ID: 3816498 • Views:

More Releases from Orion Market Research

Cryptococcosis Drugs Market Share and Competitive Dynamics | Gilead Sciences, Merck, Pfizer, Johnson & Johnson
Cryptococcosis Drugs Market Share and Competitive Dynamics | Gilead Sciences, Me …
Cryptococcosis Drugs Market: In 2024, the market was valued at around USD 5.82 billion. It is projected to reach approximately USD 8.59 billion by 2031, with a CAGR of 5.50% from 2024 to 2031. Cryptococcosis is a fungus caused by Cryptococcus neoformans and Cryptococcus gattii that mostly affects the central nervous system and lungs. People with weaker immune systems, such as those with AIDS, Hodgkin lymphoma, other lymphomas, sarcoidosis, and solid
Companion Animal Postoperative Pain Management Therapeutics Market Share and Competitive Dynamics | Zoetis, Merck, Elanco, Boehringer Ingelheim, Vetoquinol
Companion Animal Postoperative Pain Management Therapeutics Market Share and Com …
Companion Animal Postoperative Pain Management Therapeutics Market: The market size was about USD 133.5 million in 2023. It is expected to grow to approximately USD 671.4 million by 2030, with a CAGR of 6.5% from 2024 to 2032. The demand for postoperative pain relievers is increasing as the number of pet surgical operations, particularly orthopaedic and dental surgery, increases. The rising frequency of periodontal disease is likely to drive the demand
Cold Pressed Citrus Oil Market Share and Competitive Dynamics | CitroBio, Now Foods, Citrus and Allied Essences, Young Living, doTERRA
Cold Pressed Citrus Oil Market Share and Competitive Dynamics | CitroBio, Now Fo …
Cold Pressed Citrus Oil Market: In 2023, the market was valued at around USD 3.90 billion. It is anticipated to reach approximately USD 5.56 billion by 2030, with a CAGR of 5.21% from 2024 to 2030. Cold pressed citrus oil has grown in leaps and bounds, particularly used in the beauty and wellness industry. The health benefits of citrus oil have contributed significantly to the expansion of the global cold pressed
Acute Ischemic Stroke Drugs Market Share and Competitive Dynamics | Boehringer Ingelheim, Genentech, Merck, AstraZeneca, Pfizer
Acute Ischemic Stroke Drugs Market Share and Competitive Dynamics | Boehringer I …
Acute Ischemic Stroke Drugs Market: The market size was about USD 13.01 billion in 2023. It is expected to grow to approximately USD 14.0 billion by 2032, with a CAGR of 4.6% from 2023 to 2032. The posterior circulation, the anterior circulation, or both can be affected by acute ischemic stroke (AIS). The internal carotid arteries can supply oxygenated blood to the brain's anterior circulation, which includes the middle and anterior

All 5 Releases


More Releases for HISCL

Sepsis Diagnostics Market Trends, Future Outlook, COVID-19 Impact Analysis, Fore …
The global sepsis diagnostics market is estimated to grow at a significant CAGR during the forecast period. Sepsis is a major unmet medical need caused by a patient's overwhelming and life-threatening immune response to infection and can lead to tissue damage, organ failure, and even death. Sepsis affects an estimated 20-30 million people globally every year. According to the Agency for Healthcare Research and Quality, sepsis is the most expensive
Sepsis Treatment Market to Reach USD 700 million in 2025, at a CAGR of 8.5%
The global sepsis treatment market is forecast to grow at an annual rate of 8.5 percent from USD 429 million in 2019 to USD 700 million in 2025. The public-private support for target study efforts, the rising prevalence of infectious diseases, the number of sepsis incidences, and the government programs to raise sepsis awareness are all expected to fuel the market growth over the forecast period for Sepsis Treatment products. Download
Global Sepsis Diagnostics Market Size, Share, Trends and Forecast To 2019-2025
The global sepsis diagnostics market is estimated to grow at a significant CAGR during the forecast period. Sepsis is a major unmet medical need caused by a patient’s overwhelming and life-threatening immune response to infection and can lead to tissue damage, organ failure, and even death. Sepsis affects an estimated 20-30 million people globally every year. According to the Agency for Healthcare Research and Quality, sepsis is the most expensive
ELISA Analyzer Market Development History with Top Players Siemens Healthineers, …
Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can be
ELISA Analyzer Market Acknowledgement with Top Players Siemens Healthineers, Awa …
Enzyme Linked Immunosorbent Assay (ELISA) is a biochemical assay, which use antibodies and an enzyme-mediated color change to detect the presence of either antigen (proteins, peptides, and hormones) or antibody in sample. Enzyme-linked immunosorbent assay is used as diagnostic tool in medicine and analytical tool in biomedical research. ELISA analyzer is an instrument used for detecting the concentration and presence of analyte in the test sample. ELISA analyzer can be
Immunofluorescence Analyzer Market Witness Significant Growth | Abbott Laborator …
The advantages of a fluorescent detection system include higher sensitivity recognition of an analyte, simpler assay designs, and simplified reagents. Over the past few decades various advancements such as portability, compactness and real time monitoring of analyzer have supported the application of fluorescent-based immunoassay system in point-of-care. A modern immunofluorescence assay-based analyzer uses a florescent compound that absorbs light energy at a specific wavelength and emits energy at a different